Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi In a major analysis in Africa, the first vaccine approved to fight malaria cut deaths among young children by 13% over nearly 4 years, the World Health Organization (WHO) reported last week. Data from a pilot rollout of the vaccine, called […]
Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi An influenza virus variant that circulated widely before the COVID-19 pandemic has disappeared, leading an expert group that advises the World Health Organization (WHO) to recommend last week that it no longer be included in flu vaccines. https://www.science.org/content/article/news-glance-more-success-fusion-medical-tests-under-scrutiny-and-grizzly-reintroduction? The strain, known
Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi The 2023 Nobel Prize in Physiology or Medicine has been jointly awarded to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19 https://www.nobelprize.org/prizes/medicine/2023/press-release/ The discoveries by the two
Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi After the US Food and Drug Administration authorized new monovalent COVID vaccines on early last week, the Centers of Disease Control and Prevention (CDC)’s Advisory Committee on Immunization Practices backed the decision a day later with a nearly unanimous vote in favour of universal XBB-containing
Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi The U.S. Agency for International Development (USAID) has prematurely ended a $125 million program aimed at identifying viruses that might harm humans in animals. Many see this as a fallout from the concern that researchers studying bat viruses may have triggered
Article by Lalita Panicker Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi The US Department of Health and Human Services (HHS) has announced its first list of 10 prescription drugs whose prices will be open for negotiation in 2023 and 2024. Any settled price will become effective in 2026. The HHS will be
Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi The UK is nearly “flying blind” when it comes to COVID this autumn, experts have said, amid an increase in cases. While the UK Health Security Agency (UKHSA) continues to track some metrics of COVID, including hospitalization numbers, many of the
UK COVID-19 surveillance “flying blind”; The latest health stories from around the world Read More »
Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi To the relief of biomedical research advocates, a US Senate spending panel has approved a modest budget increase of 2% for the National Institutes of Health (NIH). The bump to $47.8 billion roughly matches President Joe Biden’s request for the 2024
Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi The pharmaceutical company Johnson & Johnson (J&J) in mid-July agreed to help make a therapy critical to fighting drug-resistant tuberculosis (TB) more widely available and affordable. J&J said it would allow competitors to market generic versions of the lifesaving drug, bedaquiline,
Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi DNA-based screening methods for high-risk human papillomavirus (HPV) have proven to be highly effective for early cervical cancer detection but remain too expensive and difficult to use in resource-limited settings. Kundrod et al. have developed a prototype point-of-care test for detecting
Subscribe our newsletter to stay updated
Copyright © 2023 | Health Issues Africa | All rights reserved.
